President Trump signed an executive order Monday creating the first new women’s health research division inside the National Institutes of Health in more than three decades, with First Lady Melania Trump standing beside him as the driving force behind it.
Quick Take
- President Trump signed the order October 19, 2026, directing a new Women’s Health Division to stand up inside the National Institutes of Health (NIH) within 90 days.
- The order also creates a White House Women’s Health Task Force, which will be led by White House Chief of Staff Susie Wiles.
- First Lady Melania Trump publicly championed the plan and is credited by the White House as its driving force.
- Research shows women’s health studies have long received a small slice of NIH’s budget, a gap the order aims to close.
What The Order Actually Does
The executive order, titled “Advancing Women’s Health to Improve Outcomes in All Phases of Life,” tells the Secretary of Health and Human Services, working through the NIH Director, to build a Women’s Health Division inside an existing NIH institute or center within 90 days. The division’s job is to study conditions that affect women but get little research funding, check whether past findings hold up for women, and look at how treatments work differently across a woman’s life.
Beyond the new division, the order sets up a White House Women’s Health Task Force. Susie Wiles, the president’s chief of staff, will lead it. The Department of Health and Human Services (HHS) says the task force will coordinate work across federal agencies so that new findings move faster from the lab into doctors’ offices and hospitals. That coordination piece matters because research gaps and care gaps often come from agencies working in separate silos rather than together.
A First Lady’s Public Push For a Long-Ignored Issue
White House officials say First Lady Melania Trump pushed hard to get this order across the finish line, and President Trump credited her publicly at the signing. Her office framed the move as strengthening “research, prevention, diagnosis, treatment, and care for girls and women throughout every stage of life”. That language signals the order isn’t aimed only at reproductive health, but at the full span of a woman’s medical life, from childhood through older age.
The timing lines up with growing attention on how little is known about conditions that mostly or only affect women, from autoimmune disease to menopause-related health problems. Supporters of the order argue that treating this as a national priority, backed by the First Lady’s name, gives the effort political staying power that past initiatives lacked. For conservatives who favor results over bureaucracy, the real test will be whether the division produces usable science, not just another office with a plaque on the door.
Thirty Years After Congress Tried This Once Before
This isn’t the government’s first attempt to fix this problem. Congress passed the NIH Revitalization Act in 1993, which required women be included in federally funded clinical trials and created NIH’s Office of Research on Women’s Health. Three decades later, researchers say big questions about women’s health still haven’t been answered. Federal data back that up: women’s health research made up only about 8.8 percent of NIH’s budget from fiscal years 2013 through 2023, and that share actually shrank even as NIH’s overall budget grew.
That history explains why some health researchers view new offices and task forces with cautious optimism rather than certainty. An executive order can direct agencies to act, but turning that direction into real funding, staffing, and finished studies takes years, not months. The 90-day deadline for standing up the new division is a clear, trackable benchmark, and it’s one the public and Congress can hold the administration to as the year unfolds.
Still, the order gives the issue something it hasn’t had in a long time: a named division, a dedicated budget conversation, and a task force with a direct line to the chief of staff’s office. For a policy area that has repeatedly lost ground even as federal health spending climbed, that kind of institutional backing is a meaningful starting point. Whether it closes the gap the 1993 law couldn’t fully close will depend on follow-through over the next several budget cycles.
Sources:
facebook.com, whitehouse.gov, hhs.gov, beckershospitalreview.com, bmj.com
